Asthma
Conditions
Brief summary
The aim of the study is to describe the prescribing pattern of the different types of medications which are used to treat asthma, across multiple countries.
Interventions
None listed
Sponsors
AstraZeneca
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
1. Male and female patients ≥12 years-old 2. Documented diagnosis with Asthma as per medical records. 3. Have had ≥3 consultations with the HCP at study start date 4. After full explanation, a patient or legal guardian must have signed an informed consent document indicating that they understand the purpose of and the procedures required for the study and are willing to participate in the study.
Exclusion criteria
1. Patient with a diagnosis of chronic obstructive pulmonary disease or other chronic respiratory disease different from Asthma. 2. An acute or chronic condition that, in the investigator's opinion, would limit the patient's ability to participate in this study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The main outcome will be a categorisation of SABA prescription in asthma patients. | 12 months retrospective from index date | Mild asthma patients will be categorised into 5 groups according to the number of SABA and ICS prescriptions in the 12 months prior to their index date (initial exposure window): 1. No prescriptions for asthma inhalers 2. Appropriate SABA prescription with no ICS 3. Appropriate SABA prescription with ICS 4. SABA over-prescription with no ICS 5. SABA over-prescription with ICS Moderate/severe asthma patients will be categorised into 2 groups according to the number of SABA and ICS prescriptions in the 12 months prior to their index date: 1. Appropriate SABA prescription on top of maintenance therapy 2. SABA over-prescription on top of maintenance therapy |
Countries
Argentina
Outcome results
None listed